Expression, purification, and characterization of recpmbinant rat plasminogen activator inhibitor-1

Fibrinolysis and Proteolysis

Volumn 11, Issue 1, 1997, Pages 37-43

  Ngo, T H ^a   Bijnens, A P ^a   Knockaert, I ^a   Declerck, P J ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

EID: 0030896544     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(97)80007-0     Document Type: Article

References (36)

1. Kruithof E K O, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-913.
2. Declerck P J, Juhan-Vague I, Felez J, Wiman B. Pathophysiology of fibrinolysis. J Int Med 1994; 236: 425-432.
3. Van Meijer M, Pannekoek H. Structure of plasminogen activator inhibitor l (PAI-1) and its function in fibrinolysis: an update. Fibrinolysis 1995; 9: 263-276.
4. Alessi M C, Declerck P J, De Mol M, Nelles L, Collen D. Purification and characterization of natural and recombinant human plasminogen activator inhibitor 1 (PAI-1). Eur J Biochem 1988; 175: 531-540.
5. Loskutoff DJ, Sawdey M, MimuroJ. Type 1 plasminogen activator inhibitor. Prog Hemost Thromb 1988; 9: 87-115.
6. Sprengers E D, Kluft C. Plasminogen activator inhibitors. Blood 1987;69:381-387.
7. Huber R, Carrell R W. Implications of the three-dimensional structure of a-antitrypsin for structure and function of serpins. Biochemistry 1989; 28: 8951-8966.
8. Travis J, Salvesen G S. Human plasma proteinase inhibitors. Annu Rev Biochem 1983; 52: 655-709.
9. Hekman C M, Loskutoff D J. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by dénaturants. J Biol Chem 1985; 260: 11581-11587.
10. Declerck P J, De Mol M, Alessi M C, Baudner S, Pâques E P, Preissner K T, Müller-Berghaus K T, Collen D. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. J Biol Chem 1988; 263: 5454-5461.
11. Wiman B, Almquist A, Sigurdardottir O, Lindahl T. Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma. FEES Lett 1988; 242: 125-128.
12. Booth N A, Simpson A J, Groll A, Bennet B, MacGiegar I R. Plasminogen activator inhibitor 1 (PAI-1) in plasma and platelets. Br J Haematol 1988; 70: 327-333.
13. Declerck P J, De Mol M, Vaughan D E, Collen D. Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a non-inhibitory substrate for tissue-type plasminogen activator. J Biol Chem 1992; 267: 11693-11696.
14. Emeis J J. Perfused rat hindlegs. A model to study plasminogen activator release. Thromb Res 1983; 30: 195-203.
15. Emeis J J, Brouwer A, Bareids R J, Horan M A, Durham S K, Kooistra T. On the fibrinolytic system in aged rats, and its reactivity to endotoxin and cytokines. Thromb Haemost 1992; 67:679-701.
16. Emeis JJ, Van den Hoogen, Diglio C A. The RHE rat heart endothelial cell line: a model system for studying the synthesis, storage, and acute release of tissue-type plasminogen activator. Thromb Haemost 1993; 69: 1233.
17. Gallimore M J, Tyle H M, Shaw J T B. The measurement of fibrinolysis in the rat. Thromb Diath Haemorrh 1971 ; 26: 279-309.
18. Van Giezen J J J. Modulation of fibrinolytic activity in rats and other species. PhD thesis. Unlversiteit Utrecht, The Netherlands, 1993.
19. Kurz K D, Main B W, Sandusky G E. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990; 60: 269-280.
20. Lenfors S, Margerg L, Wikstrom S, Jonsson U, Eriksson A W, Gustafsson D. A new rat model of arterial thrombosis with a platelet-rich head and an erythrocyte-rich tail: thrombolysis experiments with specific thrombin inhibition. Blood Coagul Fibrinolysis 1993; 4: 163-271.
21. Overgaard K, Lundbaek J A, Boysen G. Thrombolytic therapy in stroke-A rat model. Fibrinolysis, suppl. 2, 1990; 4: 13-14.
22. Abrahamsson T, Nerme V, Strömqvist M, Akerblom B, Legnehed A, Pettersson K, Westin Eriksson A. Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin. Thromb Haemost 1996; 75: 118-126.
23. Padro T, Quax P H, van den Hoogen C M, Roholl P, Verheijen J H, Emeis J J. Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin. Arterioscler Thromb 1994; 14: 1459-1465.
24. Galfré F, Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 1981; 73: 3-46.
25. Debrock S, Declerck P J. Neutralization of plasminogen activator inhibitor-1 inhibitory properties. Identification of two different mechanisms. Biochim Biophys Acta, in press.
26. Holvoet P, Cleemput H, Collen D. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA. Thromb Haemost 1985; 684-687.
27. Gils A, Knockaert I, Declerck P J. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop. Biochemistry 1996; 35: 7474-7481.
28. Sambrook J, Fritsch E F, Maniatis T. Molecular cloning, 2nd edn. Cold Spring Harbor, NY, 1989.
29. Sanger F, Nicklen S, Coulson A R. DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sei USA 1977; 74: 5463-5467.
30. Verheijen J H, Chang G T G, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemost 1984; 51 : 392-395.
31. Declerck P J, Verstreken M, Collen D. An immunofunctional assay for active plasminogen activator inhibitor-1 (PAI-1). Fibrinolysis, suppl. 2, 1988; 2: 77-78.
32. Zeheb R, Gelehrter T D. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene 1988; 73: 459-468.
33. Bijnens A P, Knockaert I, Cousin E, Kruithof E K O, Declerck P J. Expression and characterization of recombinant porcine plasminogen activator inhibitor 1. Thromb Haemost, in press.
34. Hofmann K J, Mayer E J, Schultz L D, Socher S H, Reilly C F. Purification and characterisation of recombinant rabbit plasminogen activator inhibitor-1 expressed in Saccharomyces cerevisiae. Fibrinolysis 1992; 6: 263-272.
35. Madison E L, Goldsmith E J, Gerard R D, Gething M J, Sambrook J E, Bassel-Duby R S. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1. Proc Natl Acad Sei USA 1990; 87: 3530-3533.
36. Wiman B, Lindahl T, Almquist A. Evidence for a discrete binding protein of plasminogen activator inhibitor in plasma. Thromb Haemost 1988; 59: 392-395.